Gongdong Medical: Net profit for the first half of the year was 50.3493 million yuan, a year-on-year decrease of 47.16%

Gongdong Medical disclosed its 2025 semi-annual report on the evening of August 25, achieving an operating income of 557 million yuan in the first half of the year, a year-on-year increase of 0.58%; the net profit attributable to the parent company was 50.3493 million yuan, a year-on-year decrease of 47.16%; basic earnings per share were 0.23 yuan. The net profit attributable to shareholders of the listed company decreased compared to the same period last year, mainly due to the impact of U.S. tariff policies and domestic medical procurement policies in the first half of the year, which led to a decline in the selling prices of some ordered products and a year-on-year decrease in gross profit; losses from investment income due to the disposal of equity accounted for using the equity method from the acquisition of Jindongsheng; a decrease in exchange gains due to fluctuations in the dollar exchange rate during the period; and a decrease in interest income during the period, among other factors